- Home
- NSA vs IDYA Comparison
NSA vs IDYA Comparison
Compare NSA & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSA
- IDYA
- Stock Information
- Founded
- NSA 2013
- IDYA 2015
- Country
- NSA United States
- IDYA United States
- Employees
- NSA N/A
- IDYA N/A
- Industry
- NSA Real Estate Investment Trusts
- IDYA Biotechnology: Pharmaceutical Preparations
- Sector
- NSA Real Estate
- IDYA Health Care
- Exchange
- NSA Nasdaq
- IDYA Nasdaq
- Market Cap
- NSA 2.3B
- IDYA 2.3B
- IPO Year
- NSA 2015
- IDYA 2019
- Fundamental
- Price
- NSA $30.59
- IDYA $26.88
- Analyst Decision
- NSA Hold
- IDYA Buy
- Analyst Count
- NSA 8
- IDYA 15
- Target Price
- NSA $34.25
- IDYA $47.92
- AVG Volume (30 Days)
- NSA 1.1M
- IDYA 1.2M
- Earning Date
- NSA 10-29-2025
- IDYA 11-03-2025
- Dividend Yield
- NSA 7.54%
- IDYA N/A
- EPS Growth
- NSA N/A
- IDYA N/A
- EPS
- NSA 0.61
- IDYA N/A
- Revenue
- NSA $741,255,000.00
- IDYA $7,000,000.00
- Revenue This Year
- NSA N/A
- IDYA $63.41
- Revenue Next Year
- NSA $2.54
- IDYA $305.49
- P/E Ratio
- NSA $49.26
- IDYA N/A
- Revenue Growth
- NSA N/A
- IDYA N/A
- 52 Week Low
- NSA $28.02
- IDYA $13.45
- 52 Week High
- NSA $46.07
- IDYA $32.67
- Technical
- Relative Strength Index (RSI)
- NSA 47.50
- IDYA 59.69
- Support Level
- NSA $29.70
- IDYA $26.77
- Resistance Level
- NSA $30.54
- IDYA $28.41
- Average True Range (ATR)
- NSA 0.47
- IDYA 0.92
- MACD
- NSA 0.01
- IDYA 0.04
- Stochastic Oscillator
- NSA 70.00
- IDYA 59.24
About NSA National Storage Affiliates Trust of Beneficial Interest
National Storage Affiliates Trust Trust is a real estate investment trust. The company owns, operates, and acquires self-storage properties located within the metropolitan statistical areas throughout the United States. With the help of property management platform, the company manages and controls the day-to-day operations and affairs of consolidated properties and unconsolidated real estate ventures under the iStorage, SecurCare, RightSpace, Northwest and Move It brands.
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.